Rodger L. Bick

6.8k total citations
180 papers, 4.5k citations indexed

About

Rodger L. Bick is a scholar working on Hematology, Internal Medicine and Surgery. According to data from OpenAlex, Rodger L. Bick has authored 180 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Hematology, 71 papers in Internal Medicine and 58 papers in Surgery. Recurrent topics in Rodger L. Bick's work include Venous Thromboembolism Diagnosis and Management (71 papers), Blood Coagulation and Thrombosis Mechanisms (60 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (47 papers). Rodger L. Bick is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (71 papers), Blood Coagulation and Thrombosis Mechanisms (60 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (47 papers). Rodger L. Bick collaborates with scholars based in United States, Australia and United Kingdom. Rodger L. Bick's co-authors include William Baker, Jawed Fareed, Jeanine M. Walenga, Eugene P. Frenkel, Debra A. Hoppensteadt, Debra Hoppensteadt, Lajos Fekete, Harold S. Kaplan, Walter Jeske and Banu Arun and has published in prestigious journals such as JAMA, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Rodger L. Bick

177 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rodger L. Bick United States 41 2.2k 1.6k 1.1k 1.1k 711 180 4.5k
Thomas Lecompte France 39 3.2k 1.5× 1.8k 1.1× 1.1k 0.9× 1.7k 1.5× 698 1.0× 239 6.6k
H K Nieuwenhuis Netherlands 44 3.6k 1.7× 956 0.6× 1.0k 0.9× 1.3k 1.2× 864 1.2× 101 6.3k
F Bachmann Switzerland 42 2.0k 0.9× 1.2k 0.8× 1.0k 0.9× 1.5k 1.3× 863 1.2× 116 5.6k
F E Preston United Kingdom 45 4.3k 2.0× 1.8k 1.2× 863 0.8× 1.8k 1.6× 624 0.9× 170 7.6k
Suzette Beguı́n Netherlands 37 4.4k 2.0× 2.1k 1.4× 1.1k 1.0× 1.8k 1.7× 823 1.2× 98 6.5k
Sherrill J. Slichter United States 46 4.6k 2.1× 645 0.4× 1.2k 1.1× 1.0k 0.9× 973 1.4× 135 8.1k
J W ten Cate Netherlands 41 2.2k 1.0× 1.9k 1.2× 1.5k 1.3× 1.4k 1.3× 808 1.1× 168 6.3k
Barbara M. Alving United States 32 2.2k 1.0× 643 0.4× 884 0.8× 443 0.4× 638 0.9× 107 4.7k
Walter A. Wuillemin Switzerland 37 1.8k 0.8× 1.0k 0.7× 665 0.6× 1.1k 1.0× 400 0.6× 130 4.6k
Ulrich Abildgaard Norway 43 3.1k 1.4× 1.5k 1.0× 1.4k 1.2× 1.6k 1.5× 1.1k 1.5× 147 6.6k

Countries citing papers authored by Rodger L. Bick

Since Specialization
Citations

This map shows the geographic impact of Rodger L. Bick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodger L. Bick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodger L. Bick more than expected).

Fields of papers citing papers by Rodger L. Bick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodger L. Bick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodger L. Bick. The network helps show where Rodger L. Bick may publish in the future.

Co-authorship network of co-authors of Rodger L. Bick

This figure shows the co-authorship network connecting the top 25 collaborators of Rodger L. Bick. A scholar is included among the top collaborators of Rodger L. Bick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodger L. Bick. Rodger L. Bick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fareed, Jawed, Rodger L. Bick, G. H. Rao, et al.. (2008). The Immunogenic Potential of Generic Version of Low-Molecular-Weight Heparins May Not be the Same as the Branded Products. Clinical and Applied Thrombosis/Hemostasis. 14(1). 5–7. 7 indexed citations
2.
Bick, Rodger L.. (2008). Alterations of Hemostasis Associated With Cardiopulmonary Bypass: Pathophysiology, Prevention, Diagnosis, and Management. Seminars in Thrombosis and Hemostasis. 3(2). 59–82. 9 indexed citations
3.
Bick, Rodger L. & William Baker. (2008). Treatment Options for Patients Who Have Antiphospholipid Syndromes. Hematology/Oncology Clinics of North America. 22(1). 145–153. 5 indexed citations
4.
Zhu, He, Debra Hoppensteadt, Cafer Adıgüzel, Rodger L. Bick, & Jawed Fareed. (2007). Comparison of Immunogenic Potentials of Bovine Thrombin Preparations. Clinical and Applied Thrombosis/Hemostasis. 15(1). 41–49. 2 indexed citations
5.
Bick, Rodger L., et al.. (2006). Dengue Fever and Thrombocytopenia: A Deadly Duo.. Blood. 108(11). 3978–3978. 1 indexed citations
6.
Hoppensteadt, Debra, Jeanine M. Walenga, Jawed Fareed, & Rodger L. Bick. (2003). Heparin, low–molecular-weight heparins, and heparin pentasaccharide. Hematology/Oncology Clinics of North America. 17(1). 313–341. 42 indexed citations
7.
Bick, Rodger L.. (2003). Introduction to thrombosis. Hematology/Oncology Clinics of North America. 17(1). 1–8. 6 indexed citations
8.
Fareed, Jawed, Debra A. Hoppensteadt, & Rodger L. Bick. (2003). Management of Thrombotic and Cardiovascular Disorders in the New Millenium. Clinical and Applied Thrombosis/Hemostasis. 9(2). 101–108. 18 indexed citations
9.
Fareed, Jawed, Debra Hoppensteadt, Walter Jeske, Sarfraz Ahmad, & Rodger L. Bick. (1999). Acquired Defects of Fibrinolysis Associated with Thrombosis. Seminars in Thrombosis and Hemostasis. 25(4). 367–374. 22 indexed citations
10.
Frenkel, Eugene P. & Rodger L. Bick. (1999). Prothrombin G20210A Gene Mutation, Heparin Cofactor II Defects, Primary (Essential) Thrombocythemia, and Thrombohemorrhagic Manifestations. Seminars in Thrombosis and Hemostasis. 25(4). 375–386. 11 indexed citations
11.
Bick, Rodger L.. (1999). Therapy for Venous Thrombosis: Guidelines for a Competent and Cost-effective Approach. Clinical and Applied Thrombosis/Hemostasis. 5(1). 2–9. 12 indexed citations
12.
Bick, Rodger L. & Jawed Fareed. (1997). Current Status of Thrombosis: A Multidisciplinary Medical Issue and Major American Health Problem—Beyond the Year 2000. Clinical and Applied Thrombosis/Hemostasis. 3(1_suppl). S1–S5. 11 indexed citations
13.
Bick, Rodger L., et al.. (1995). The Antiphospholipid and Thrombosis (APL-T) Syndromes: Clinical and Laboratory Correlates. Clinics in Laboratory Medicine. 15(1). 63–84. 13 indexed citations
14.
Bick, Rodger L. & James Strauss. (1995). Thrombolytic Therapy and Its Uses. Laboratory Medicine. 26(5). 330–337. 1 indexed citations
15.
Bick, Rodger L., et al.. (1995). Fetal Wastage Syndrome due to Blood Protein/Platelet Defects: Results of Prevalence Studies and Treatment Outcome with Low-Dose Heparin and Low-Dose Aspirin. Clinical and Applied Thrombosis/Hemostasis. 1(4). 286–292. 18 indexed citations
16.
Fareed, Jawed, Rodger L. Bick, Debra A. Hoppensteadt, et al.. (1995). Molecular Markers of Hemostatic Activation: Implications in the Diagnosis of Thrombosis, Vascular, and Cardiovascular Disorders. Clinics in Laboratory Medicine. 15(1). 39–61. 16 indexed citations
17.
Bick, Rodger L.. (1994). Disseminated intravascular coagulation: Objective Criteria for Diagnosis and Management. Medical Clinics of North America. 78(3). 511–543. 46 indexed citations
18.
Bick, Rodger L.. (1993). Hematology : clinical and laboratory practice. 76 indexed citations
19.
Bick, Rodger L.. (1992). Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice. Medical Entomology and Zoology. 46 indexed citations
20.
Bick, Rodger L. & E.J. Ross. (1985). Clinical Use of Intrapulmonary Heparin. Seminars in Thrombosis and Hemostasis. 11(2). 213–217. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Lecompte Breakdown of academic impact, for papers by H K Nieuwenhuis Breakdown of academic impact, for papers by F Bachmann Breakdown of academic impact, for papers by F E Preston Breakdown of academic impact, for papers by Suzette Beguı́n Breakdown of academic impact, for papers by Sherrill J. Slichter Breakdown of academic impact, for papers by J W ten Cate Breakdown of academic impact, for papers by Barbara M. Alving Breakdown of academic impact, for papers by Walter A. Wuillemin Breakdown of academic impact, for papers by Ulrich Abildgaard
Rankless by CCL
2026